Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: A review

Gregory A. Helm, Tord D. Alden, Jason P. Sheehan, David F Kallmes

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

OBJECTIVE: To review the uses of bone morphogenetic proteins (BMPs) and BMP gene therapy for the treatment of neurosurgical disorders. METHODS: Literature review. RESULTS: BMPs are members of the transforming growth factor β superfamily, and they play an important role in the growth and development of numerous tissues, including bone, brain, and spinal cord. Although the majority of previous studies have focused on the regulatory functions of BMPs in the normal growth and differentiation of the skeletal system, BMPs also seem to be exquisitely involved in the regulation of cellular proliferation, survival, differentiation, apoptosis, and lineage commitment in the central nervous system. When specific BMPs are delivered on biological matrices, they have the capacity to induce bone, cartilage, ligament, and tendon at both heterotopic and orthotopic sites, suggesting that they may play a major role in the future treatment of spinal and craniofacial pathology. For example, recent studies have clearly demonstrated the usefulness of BMPs and BMP gene therapy for the induction of spinal arthrodesis in several animal models. In addition, several BMPs have been shown to have a neuroprotective effect in animal models of head injury, cerebral ischemia, and Parkinson's disease and may therefore have direct clinical applications for the treatment of central nervous system disorders. CONCLUSION: As the physiological activity of BMPs in the development and pathology of the central nervous system and spine are more fully elucidated, BMP therapeutics and gene therapy will probably have numerous applications in neurological surgery.

Original languageEnglish (US)
Pages (from-to)1213-1222
Number of pages10
JournalNeurosurgery
Volume46
Issue number5
StatePublished - May 2000
Externally publishedYes

Fingerprint

Bone Morphogenetic Proteins
Genetic Therapy
Central Nervous System
Animal Models
Pathology
Bone and Bones
Arthrodesis
Central Nervous System Diseases
Transforming Growth Factors
Neuroprotective Agents
Therapeutics
Brain Ischemia
Growth and Development
Craniocerebral Trauma
Ligaments
Tendons
Cartilage
Parkinson Disease
Spinal Cord
Spine

Keywords

  • Bone morphogenetic proteins
  • Gene therapy
  • Head injury
  • Spinal fusion
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery : A review. / Helm, Gregory A.; Alden, Tord D.; Sheehan, Jason P.; Kallmes, David F.

In: Neurosurgery, Vol. 46, No. 5, 05.2000, p. 1213-1222.

Research output: Contribution to journalArticle

Helm, Gregory A. ; Alden, Tord D. ; Sheehan, Jason P. ; Kallmes, David F. / Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery : A review. In: Neurosurgery. 2000 ; Vol. 46, No. 5. pp. 1213-1222.
@article{d865c4b5b2c94128845d6005bb8e51ca,
title = "Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: A review",
abstract = "OBJECTIVE: To review the uses of bone morphogenetic proteins (BMPs) and BMP gene therapy for the treatment of neurosurgical disorders. METHODS: Literature review. RESULTS: BMPs are members of the transforming growth factor β superfamily, and they play an important role in the growth and development of numerous tissues, including bone, brain, and spinal cord. Although the majority of previous studies have focused on the regulatory functions of BMPs in the normal growth and differentiation of the skeletal system, BMPs also seem to be exquisitely involved in the regulation of cellular proliferation, survival, differentiation, apoptosis, and lineage commitment in the central nervous system. When specific BMPs are delivered on biological matrices, they have the capacity to induce bone, cartilage, ligament, and tendon at both heterotopic and orthotopic sites, suggesting that they may play a major role in the future treatment of spinal and craniofacial pathology. For example, recent studies have clearly demonstrated the usefulness of BMPs and BMP gene therapy for the induction of spinal arthrodesis in several animal models. In addition, several BMPs have been shown to have a neuroprotective effect in animal models of head injury, cerebral ischemia, and Parkinson's disease and may therefore have direct clinical applications for the treatment of central nervous system disorders. CONCLUSION: As the physiological activity of BMPs in the development and pathology of the central nervous system and spine are more fully elucidated, BMP therapeutics and gene therapy will probably have numerous applications in neurological surgery.",
keywords = "Bone morphogenetic proteins, Gene therapy, Head injury, Spinal fusion, Stroke",
author = "Helm, {Gregory A.} and Alden, {Tord D.} and Sheehan, {Jason P.} and Kallmes, {David F}",
year = "2000",
month = "5",
language = "English (US)",
volume = "46",
pages = "1213--1222",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery

T2 - A review

AU - Helm, Gregory A.

AU - Alden, Tord D.

AU - Sheehan, Jason P.

AU - Kallmes, David F

PY - 2000/5

Y1 - 2000/5

N2 - OBJECTIVE: To review the uses of bone morphogenetic proteins (BMPs) and BMP gene therapy for the treatment of neurosurgical disorders. METHODS: Literature review. RESULTS: BMPs are members of the transforming growth factor β superfamily, and they play an important role in the growth and development of numerous tissues, including bone, brain, and spinal cord. Although the majority of previous studies have focused on the regulatory functions of BMPs in the normal growth and differentiation of the skeletal system, BMPs also seem to be exquisitely involved in the regulation of cellular proliferation, survival, differentiation, apoptosis, and lineage commitment in the central nervous system. When specific BMPs are delivered on biological matrices, they have the capacity to induce bone, cartilage, ligament, and tendon at both heterotopic and orthotopic sites, suggesting that they may play a major role in the future treatment of spinal and craniofacial pathology. For example, recent studies have clearly demonstrated the usefulness of BMPs and BMP gene therapy for the induction of spinal arthrodesis in several animal models. In addition, several BMPs have been shown to have a neuroprotective effect in animal models of head injury, cerebral ischemia, and Parkinson's disease and may therefore have direct clinical applications for the treatment of central nervous system disorders. CONCLUSION: As the physiological activity of BMPs in the development and pathology of the central nervous system and spine are more fully elucidated, BMP therapeutics and gene therapy will probably have numerous applications in neurological surgery.

AB - OBJECTIVE: To review the uses of bone morphogenetic proteins (BMPs) and BMP gene therapy for the treatment of neurosurgical disorders. METHODS: Literature review. RESULTS: BMPs are members of the transforming growth factor β superfamily, and they play an important role in the growth and development of numerous tissues, including bone, brain, and spinal cord. Although the majority of previous studies have focused on the regulatory functions of BMPs in the normal growth and differentiation of the skeletal system, BMPs also seem to be exquisitely involved in the regulation of cellular proliferation, survival, differentiation, apoptosis, and lineage commitment in the central nervous system. When specific BMPs are delivered on biological matrices, they have the capacity to induce bone, cartilage, ligament, and tendon at both heterotopic and orthotopic sites, suggesting that they may play a major role in the future treatment of spinal and craniofacial pathology. For example, recent studies have clearly demonstrated the usefulness of BMPs and BMP gene therapy for the induction of spinal arthrodesis in several animal models. In addition, several BMPs have been shown to have a neuroprotective effect in animal models of head injury, cerebral ischemia, and Parkinson's disease and may therefore have direct clinical applications for the treatment of central nervous system disorders. CONCLUSION: As the physiological activity of BMPs in the development and pathology of the central nervous system and spine are more fully elucidated, BMP therapeutics and gene therapy will probably have numerous applications in neurological surgery.

KW - Bone morphogenetic proteins

KW - Gene therapy

KW - Head injury

KW - Spinal fusion

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0034058144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034058144&partnerID=8YFLogxK

M3 - Article

C2 - 10807254

AN - SCOPUS:0034058144

VL - 46

SP - 1213

EP - 1222

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 5

ER -